IIT Palakkad creates sensor technology for real-time heparin monitoring

Precise heparin dosing remains a critical challenge in modern medicine, with significant consequences for patient safety. Heparin, an anticoagulant widely used in cardiac surgery, dialysis, and other medical procedures, requires careful calibration—insufficient doses risk dangerous blood clot formation, while excessive administration can trigger severe bleeding complications.

Scientists at the Indian Institute of Technology Palakkad have addressed this clinical gap by developing specialized sensor technology capable of providing rapid heparin level monitoring. The innovation represents a potential breakthrough for healthcare providers who currently rely on conventional laboratory tests that consume valuable time in clinical settings.

The sensor technology is designed to deliver real-time or near-real-time measurements of heparin concentration in patient blood samples. This capability would enable medical teams to make more informed, faster dosing adjustments during procedures, reducing the window of therapeutic uncertainty that poses risks to patients.

The development comes as hospitals across India and the region increasingly seek point-of-care diagnostic solutions that can improve clinical outcomes while reducing procedure duration. The IIT Palakkad research contributes to this broader trend toward decentralized, rapid-response medical testing technologies.